Post-endoscopic retrograde cholangiopancreatography bowel evisceration in a liver transplant recipient previously treated with atezolizumab-bevacizumab: first report.
증례보고
1/5 보강
Hepatocellular carcinoma (HCC) treatment increasingly involves liver transplantation (LT), often after downstaging therapies.
APA
Santos-Pérez E, Gomercic C, et al. (2026). Post-endoscopic retrograde cholangiopancreatography bowel evisceration in a liver transplant recipient previously treated with atezolizumab-bevacizumab: first report.. Revista espanola de enfermedades digestivas, 118(2), 109-110. https://doi.org/10.17235/reed.2025.11518/2025
MLA
Santos-Pérez E, et al.. "Post-endoscopic retrograde cholangiopancreatography bowel evisceration in a liver transplant recipient previously treated with atezolizumab-bevacizumab: first report.." Revista espanola de enfermedades digestivas, vol. 118, no. 2, 2026, pp. 109-110.
PMID
41128087 ↗
Abstract 한글 요약
Hepatocellular carcinoma (HCC) treatment increasingly involves liver transplantation (LT), often after downstaging therapies. Atezolizumab, a PD-L1 inhibitor, combined with bevacizumab, an anti-VEGF agent, is widely used, showing high response rates pre-transplant. However, bevacizumab impairs angiogenesis and can significantly increase the risk of wound dehiscence, infection, and delayed healing after major surgery, including LT.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.